Abeona Therapeutics (ABEO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -37,266 | -17,075 | 71,183 | 91,643 | 96,804 |
| Depreciation Amortization | 1,702 | 869 | 3,563 | 2,471 | 1,583 |
| Accounts receivable | -3,247 | -53 | -6,147 | N/A | N/A |
| Other Working Capital | -10,466 | -1,456 | -5,387 | -4,794 | 12,231 |
| Other Operating Activity | 11,977 | -2,089 | -139,538 | -147,693 | -147,804 |
| Operating Cash Flow | $-37,300 | $-19,804 | $-76,326 | $-58,373 | $-37,186 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 22,063 | 5,898 | -39,363 | -50,070 | 12,037 |
| PPE Investments | -1,414 | -935 | -7,975 | -6,822 | -4,302 |
| Net Acquisitions | N/A | N/A | 152,366 | N/A | N/A |
| Sale Of Investment | N/A | N/A | N/A | 152,366 | 152,366 |
| Investing Cash Flow | $20,649 | $4,963 | $105,028 | $95,474 | $160,101 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -5,556 | -2,222 | N/A | N/A | N/A |
| Common Stock Issued | N/A | N/A | 26,077 | 22,463 | 17,300 |
| Other Financing Activity | -1 | 0 | -37 | -37 | -37 |
| Financing Cash Flow | $-5,557 | $-2,222 | $26,040 | $22,426 | $17,263 |
| Beginning Cash Position | 78,437 | 78,437 | 23,695 | 23,695 | 23,695 |
| End Cash Position | 56,229 | 61,374 | 78,437 | 83,222 | 163,873 |
| Net Cash Flow | $-22,208 | $-17,063 | $54,742 | $59,527 | $140,178 |
| Free Cash Flow | |||||
| Operating Cash Flow | -37,300 | -19,804 | -76,326 | -58,373 | -37,186 |
| Capital Expenditure | -1,414 | -935 | -7,975 | -6,822 | -4,302 |
| Free Cash Flow | -38,714 | -20,739 | -84,301 | -65,195 | -41,488 |